App-Quantinova.ai

Persistence of circulating tumor cells in high risk early breast cancer patients during follow-up care suggests poor prognosis Results from the adjuvant SUCCESS A trial

Janni W - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Cyclophosphamide

Pilot study of prognostic utility of circulating tumor cells (CTCs) assessed by AdnaGen technology and clinical outcome of patients with stage III breast cancer who completed locoregional and systemic treatment

Alvarez RH - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

The DETECT study program Personalized treatment in metastatic breast cancer based on circulating tumor cells

Schramm A - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Doxorubicin Hydrochloride

Early change in topoisomerase 1 (Top1) positive circulating tumor cells (CTCs) is associated with overall survival (OS) in patients with advanced breast cancer after treatment with etirinotecan pegol

Rugo HS - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

etirinotecan pegol

Phase II trial of neoadjuvant chemotherapy with carboplatin and nab-paclitaxel in patients with triple negative locally advanced and inflammatory breast cancer

Somlo G - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Carboplatin

In primary breast cancer patients with HER2-negative tumors, HER2-positive circulating tumor cells with stem cell character predict worse outcome

Kasimir-Bauer S - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Predictors for discordance in HER2 phenotype between primary tumor and circulating tumor cells in women with metastatic breast cancer

Janni W - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Distinct clinical and biological values of subpopulations of circulating tumor cells (CTCs) in primary breast cancer

Mego M - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Circulating tumor cells in triple-negative and non-triple negative breast cancer patients show different genetic profiles

Bittner A-K - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Triple-negative breast cancer

N/A

Impact of apoptotic circulating tumor cells in metastatic breast cancer

Wallwiener M - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Collection, high-resolution imaging, and single cell isolation of circulating tumor cells from patient derived xenograft models using the AccuCyte CyteFinder system

Ramirez AB - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Initial circulating tumor cell count and venous thrombosis-free interval in the course of metastatic breast cancer

Beinse G - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Obesity associated factors are inversely associated with circulating tumor cells in metastatic breast cancer

Dowling RJO - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Circulating cells from the tumor microenvironment as liquid biopsy biomarkers alongside circulating tumor cells in metastatic breast cancer

Parajuli R - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Detection of activating estrogen receptor 1 (ESR1) mutation on single circulating tumor cells from metastatic breast cancer patients

Paolillo C - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Association of inflammatory and tumor markers with circulating tumor cells in metastatic breast cancer

Lohmann AE - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

CA15-3

EpCAM-independent enrichment approach for isolation of circulating tumor cells (CTCs) in breast cancer - What can be found in the EpCAM-depleted fraction?

Fehm T - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Hyaluronic acid

Detection and characterization of CTCs isolated by ScreenCell-Filtration in metastatic breast cancer

Mu Z - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Discovery of putative circulating tumor cells through somatic mutation profile of epithelial cell adhesion molecule positive single cells from blood of metastatic breast cancer patients

Lee H-B - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

The proliferation index of circulating tumor cells (CTCs) is not influenced by the administration of adjuvant chemotherapy in early breast cancer (BC) and seems to reflect Ki67 expression of the primary tumor

Agelaki S - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Filters

1671 Abstracts